117 results on '"Cacciola, Emma"'
Search Results
2. Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings
3. Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values
4. Polycyhemia Vera and Immune Thrombogenesis
5. Studies on Antiphospholipid Syndrome
6. Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia
7. Ropeginterferon alfa-2b vs Phlebotomy in Low-Risk Patients with Polycythemia Vera (Low-PV): A Randomized Phase II Clinical Trial
8. Morning Vs Bedtime Aspirin Intake in Patients with Essential Thrombocyhemia
9. Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale
10. Aspirin-treated essential thrombocythemia patients: which timing?
11. Heterozygosity for JAK2V617F is a risk factor of developing post-polycythemia vera myelofibrosis?
12. Heterozygous for JAK2V617F is a risk factor of developing post-polycythemia vera myelofibrosis?
13. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms
14. Jak2 V617F mutation testing in polycythemai vera and polycythemia vera-like disease. Impact on thrombotic risk
15. Elective laparoscopic cholecystectomy
16. Effect of heterozygous of JAK2V617F on thrombotic risk in patients with polycythemia vera: measuring the uncertain
17. Interleukin-8 levels in patients with essential thrombocythemia
18. Postsplenectomy Portal Vein Thrombosis: Personal Experience and Review of the Literature
19. Cytoreductive combination therapy in essential trhombocythemia: preliminary report of the Registro Italiano trombocitemia (RIT)
20. Expression of heterozygous or homozygous Jak2V617F in patients with polycythemia vera
21. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycthemia vera and essential thrombocythemia
22. Recurent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
23. Influence of thrombocythosis on endothelial and coagulant activation in patients with essential thrombocythemia
24. Plasmin/alpha2-antiplasmin and platelet, thrombin and fibrinolysis markers in patients with essential thrombocythemia and polycythemia vera
25. Anagrelide corrects the endothelial fiunction in patients with essential thrombocythemia
26. Tissue-palsminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in essential thrombocythemia and polycythemia vera
27. Peg Interferon a- 2b (Peg Intron) in essential Thrombocythemia
28. Peg-Interferon -2b in essential thrombocythemia: phase II study for de- termination of the minimum effective, safe and tolerated dose. Prelimina- ry data
29. Is platelet surface P-selectin an useful test for platelet function in myelo- proliferative disorders?
30. Heterozygous thalassemia associated with primary thrombocythemia
31. Essential Thrombocythaemia: prognostic factors in the italian series of two thousand patients
32. Chronic idiopathic thrombocytopenic purpura: is there any factor to predict the response to splenectomy?
33. Platelet surface P-selectin in myeloproliferative disorders
34. High circulating VCAM-1 and ICAM-1 serum levels in chronic myeloprolife- rative disorders could indicate a latent vascular endothelial dysfunction
35. Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale
36. Trombocitemia essenziale: aspetti diagnostici e terapeutici nella casistica ita- liana
37. Ruolo prognostico della timidina kinasi (TK) in pazienti affetti da leucemia linfatica cronica (LLC) trattati con fludarabina
38. La fibrosi midollare nella trombocitemia essenziale: studio osservazionale retrospettivo
39. ECLAP Cooperative Group. A Randomized Trial
40. Bone marrow biopsy analysis in essential thrombocythemia
41. B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34
42. Spontaneous and drug-related apoptosis in early and advanced chronic lymphocytic lekemia
43. Apoptosi spontanea e indotta nella lecemia linfatica cronica in stadio ini- ziale e avanzato
44. Thalassemia intermedia in patients from East Sicily: molecular basis and phenotypes
45. Autologous PBPC infusions may restore T-cells immunosuppression induced by fludarabine in NHL patients treated with fluda-mitoxantrone containing regimen. Preliminary experience
46. In vitro activity of topotecan alone or in combination with fludarabine on B- CLL cells
47. European Collaboration on Low-dose Aspirin in Polythemia Vera (ECLAP) Study: studio clinico controllato con aspirina a basse dosi per la prevenzione degli eventi trombotici nella policitemia vera
48. Combined use of ATRA plus ARA-C enhances terminal differentiation mediated apoptosis in CML cells
49. Autologous peripheral blood progenitor cells transplantation after high dose mitoxantrone containing regimens may be followed by slow hemopoietic reconstitution
50. All-Trans retinoic acid (ATRA) induced apoptosis in peripheral freshly iso- lated chronic myeloid leukemia cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.